Skip to main content
Sequana Medical N.V. logo

Sequana Medical N.V. — Investor Relations & Filings

Ticker · SEQUA ISIN · BE0974340722 LEI · 8755009AN12Y4PEOII07 BR Manufacturing
Open in API
Filings indexed 501 across all filing types
Latest filing 2024-07-05 Share Issue/Capital Cha…
Country BE Belgium
Listing BR SEQUA

About Sequana Medical N.V.

https://www.sequanamedical.com/

Sequana Medical N.V. is a commercial-stage medical device company focused on developing treatments for drug-resistant fluid overload, a frequent complication in patients with liver disease, heart failure, and cancer. The company's primary product is the alfapump®, a fully implanted, wirelessly charged system that automatically and continuously removes ascites (fluid accumulation in the abdomen) into the bladder for natural elimination. It is the first U.S. FDA-approved active implantable medical device for treating recurrent or refractory ascites due to liver cirrhosis, designed to reduce or eliminate the need for therapeutic paracentesis. Sequana Medical is also advancing its DSR® (Direct Sodium Removal) therapy platform, a novel approach for managing fluid overload in heart failure patients.

Recent filings

Filing Released Lang Actions
Sequana Medical - RSU and Retention Shares - Closing PR (ENG).pdf
Share Issue/Capital Change Classification · 99% confidence The document is titled "SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES" and details an increase in share capital due to the issuance of new shares related to RSU plans and management subscriptions. It explicitly mentions the change in share capital amount and the total number of issued and outstanding shares, as well as outstanding subscription rights, options, and warrants. This directly relates to changes in the company's capital structure and share count. Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA). It is not a general earnings release (ER), a full annual report (10-K), or a simple dividend notice (DIV).
2024-07-05 English
Sequana - RSU and Retention Shares - Closing PR (NL).pdf
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated July 5, 2024, titled in Dutch, announcing an increase in the company's capital and the total number of shares issued due to the subscription of new shares by non-executive directors (RSU plan) and management (share issuance price mentioned). It details the resulting changes in share capital and outstanding shares, and lists various outstanding options and warrants that could lead to future share issuance. The document explicitly states it is a 'PERSBERICHT GEREGLEMENTEERDE INFORMATIE' (Regulated Information Press Release) and discusses capital structure changes, including the issuance of new shares and the details of options/warrants. This directly aligns with the definition of 'Capital/Financing Update' (CAP), which covers fundraising, financing activities, or capital structure changes. It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS) because the core subject is a specific capital increase event.
2024-07-05 Dutch
Sequana-Medical-NV-AGM-EGM-2024-Results-PR-ENG.pdf
AGM Information Classification · 99% confidence The document is explicitly titled "Sequana Medical announces results of Annual and Extraordinary General Meetings of Shareholders." It details the approval of various resolutions presented at these meetings, including financial approvals for the year ended December 31, 2023, remuneration policy approval, and capital structure authorizations. This content directly relates to the outcomes and proceedings of a shareholder meeting, matching the definition for AGM Information (AGM-R). Although it mentions financial results (related to 31 Dec 2023), the primary focus and announcement structure are centered on the meeting's outcomes, not a standalone Earnings Release (ER) or Interim Report (IR). It is not a proxy statement (PSI) as it reports the results, not solicits votes.
2024-05-23 English
Sequana-Medical-NV-AGM-EGM-2024-Results-PR-NL.pdf
AGM Information Classification · 98% confidence The document is titled "Sequana Medical kondigt de resultaten van de Jaarlijkse en Buitengewone Algemene Vergaderingen van Aandeelhouders aan" (Sequana Medical announces the results of the Annual and Extraordinary General Meetings of Shareholders). It explicitly states that all proposed resolutions presented at the Annual and Extraordinary General Meetings (AGM/EGM) were approved on May 23, 2024. This content directly relates to the outcomes of a shareholder meeting. Although it is presented as a press release, the core subject matter is the declaration of voting results from a general meeting. This aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not the AGM presentation itself (AGM-R), nor is it a general earnings release (ER) or a proxy statement (PSI).
2024-05-23 Dutch
Sequana-Medical-NV-AGM-2024-minutes-ENG-FINAL.pdf
AGM Information Classification · 100% confidence The document is the official minutes of an Ordinary General Shareholders' Meeting (AGM) for Sequana Medical. It details the agenda items, proposed resolutions, and the conduct of the meeting held on May 23, 2024. Since it contains the proceedings and materials shared during the AGM, it falls under the AGM-R category.
2024-05-23 English
Sequana-Medical-NV-AGM-2024-minutes-NL-FINAL.pdf
AGM Information Classification · 100% confidence The document is the official minutes ('Notulen') of the Annual General Meeting (AGM) of Sequana Medical held on May 23, 2024. It details the agenda items, voting proposals, and resolutions passed during the meeting, such as the approval of financial statements, remuneration reports, and the reappointment of the auditor. This falls directly under the category of AGM Information/Materials.
2024-05-23 Dutch

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.